Usana Health Sciences reported flat net sales in the second quarter of its 2014 fiscal year. Issues in China caused the company to miss analysts’ estimates for sales and earnings, and the company’s share price took a plunge as a result.
The past year has been a tough one for the sales of dietary supplements, and retailing giant GNC is not immune to those trends. In the company’s second quarter 2014 earnings GNC reported declines in both overall revenue and net income year-over-year.
Herbalife's share price dropped sharply yesterday as the company reported second quarter earnings that missed analysts’ estimates. Shares dropped 11% almost immediately on the news and declined further in early trading today, with a share price...
MusclePharm Corporation, a Denver, CO-based manufacturer of sports nutrition products, continued its meteoric rise by posting a 51% rise in net sales in the second quarter of 2013.
Supplements giant NBTY generated modest sales growth in the third quarter of 2013, with strong growth in branded supplements partially offset by a decline in private label and contract manufacturing sales.
Natural Grocers by Vitamin Cottage, Inc., a major dietary supplements and organic foods retailer, has reported 30.5% sales growth and double digit comparable store sales growth in the third quarter of fiscal 2013.
As part of its year end earnings report, Cyanotech Corporation says its spriulina and astaxanthin products have achieved 50% market share in the natural channel. The Hawaii-based algae producer also said net sales had increased by 12% year over year.
In the wake of an FDA announcement on DMAA, GNC is moving to gradually remove all DMAA-containing products from its shelves, but not because the company believes that the ingredient is unsafe.
Nutraceutical International Corp. posted a 5% growth in net sales in the second quarter in earnings released yesterday. The company brought in $53.6 million in net sales in the quarter, compared to $53.9 million in the same period a year earlier.
GNC is pushing strongly ahead with a social media marketing campaign to further expand its “unique customer base” said CEO Joe Fortunato in the company’s fourth quarter earnings call.
Microalgae producer Cyanotech recorded a record $7.2 million in sales in the third quarter, an 8% rise year-over-year. Net income declined, however, coming at at $607,000 compared to $1.1 million a year earlier.
GNC is ramping up its already brisk pace of new product introductions to drive future growth, CEO Joe Fortunato said in a Q3 earnings conference call on Thursday.
BASF’s nutrition and health unit (N&H) earned €492m in Q3 – 4% more for the quarter than in 2011 when it had sales of €471m – despite falling prices for most vitamins.
Branded supplements such as MegaRed and Digestive Advantage now account for almost nine out of every 10 dollars of revenue generated by Schiff Nutrition International, bosses have revealed.
Direct selling supplements giant Herbalife now manufactures almost a third of its products in-house and will significantly increase this percentage in the coming years.
Strong growth for Herbalife in the US is being driven by a new breed of young distributors dubbed ‘Generation H’, according to the direct sales supplement giant.
Hawaii-based microalgae specialist Cyanotech has posted a surge in third quarter net income driven by "exceptional growth" in sales of the potent red antioxidant astaxanthin.
DuPont benefited from last year’s acquisition of Danish specialty food ingredient company Danisco in the fourth quarter of 2011, as revenue more than doubled in its nutrition and health business – although the chemical group’s overall profit fell slightly.
Canadian krill oil firm Neptune Technologies & Bioressources has posted a 20% rise in third-quarter revenues to $5.12m in its nutraceuticals business and a $869,000 net profit compared with a $13,000 loss for the same period the previous year.
While BOGO (buy one get one at a discount) offers have their uses, an over reliance on them is not in anyone’s best interests, according to the boss of supplement maker Schiff Nutrition.
Dupont, which earlier in the year warned that its May $6.49bn acquisition of Danisco would dent its yearly profits, has defied expectations in second quarter results published today.
Increased sales of nutritional ingredients in both the infant formula and non-infant formula markets plus the acquisition of health and wellness company Amerifit helped Martek Biosciences achieve a 30 per cent increase in 2010 revenues to reach $450m.
Martek Biosciences says a strong financial performance will allow the firm to launch a number of consumer branded products next year, while it continues to explore other complementary business opportunities.
Recently floated Chr Hansen has reported 11 percent growth in revenue for the first three quarters of 2009/10, with increased across all three of its business divisions.
ChromaDex is optimistic about its stronghold in the food and supplement sector following a strong first quarter, which saw a revenue increase of 34 percent.
Martek Biosciences Corporation has almost matched its Q3 profit results from 2008, despite sales falling 12 per cent, as cost-cutting measures and productivity gains have bolstered its results despite dwindling customer stock levels.
Microalgae supplier Cyanotech said an increased productivity for spirulina and astaxanthin have helped lift its business out of loss in the second quarter.
Strong international sales contribute to 20 per cent growth in third quarter earnings for Los Angeles-based nutritional supplement firm Herbalife, but a weak fourth quarter forecast disappoints Wall Street.
SunOpta is catching up on filing its financial results and has announced a rise in profits in the first quarter of this year despite hefty professional fees relating to its berry division write-down.
Collaboration with customers, cautious pricing, a simplified
structure and innovation all helped Kerry Ingredients achieve
profit increases despite soaring raw material costs.
The Canadian food group SunOpta announced a drop in Q3 operating
profits over the same quarter last year due to losses from its
sunflower division, but reports its food division's operating
profits increased over 50 percent on...
Forbes Medi-Tech has reported an increase in sales of its Reducol
branded sterols in Q2 2006 by 32 per cent compared to last year,
but losses deepen with dearer development, marketing and sales
costs.
Annual sales at Cyanotech dropped by three percent, as a 27 percent
hike in fourth quarter sales was not enough to offset issues that
beset the Hawaiian microalgae producer in the second and third
quarters.
Bravo! Foods is planning to increase production capacity of its
fortified flavored milk products - a plan that will be facilitated
by almost $19 million in equity financing.
Cyanotech slipped into the red in 2Q 2006 as a result of
fluctuating spirulina sales and ongoing issues with the Japanese
aquaculture market; meanwhile astaxanthin picked up some of the
slack.
Joint health continues to be a major growth area for Weider
Nutrition International, which yesterday reported a 9.8 percent
increase in sales of Q1 2006 driven by joint care brands.
Better results for Cyanotech in its first quarter 2006 suggest that
it is recovering from the short, sharp shock dealt to the Japanese
aquaculture market by last year's typhoon. The adaption of its
microalgae facilities should...
Galaxy Nutritional Food's full year 2005 results were impacted by
high raw materials costs and bad debt, but the company remains
optimistic that an earnings turnaround is on the cards for 2006,
especially with the divestment...
Leiner Health Care buffered the impact of negative publicity about
vitamin E in fiscal 2005 by shifting its focus to joint care
products, writes Jess Halliday.
The stockpiles of Martek products being held by the firm's
customers caused a slowdown in revenue growth for the second
quarter but it claims that extra capacity coming on stream this
year will see a new surge in demand, reports...
Over the past year Cyanotech has had to contend with the impact of
poor weather conditions on sales and the cost of necessary
maintenance and expansion programs - and still managed to achieve
sales broadly in line with the previous...
Rising raw material costs lead to decline of $0.58m in Galaxy's
gross margin for 3Q 2005, leading to price hikes and expense cuts
throughout the remainder of the fiscal year.
Martek Biosciences last week announced its year-end results, noting
increased revenues and "robust growth" due primarily to higher
sales of nutritional products to the company's infant formula
licensees.
